PARP-INHIBITORS ROLE IN THE TREATMENT OF OVARIAN CANCER

被引：0
|
作者：
Mahon, Lauren [1 ]
机构：
[1] Univ Rochester, Rochester, NY USA
来源：
ONCOLOGY NURSING FORUM | 2023年 / 50卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PARP inhibitors in ovarian cancer
    Goldlust, Ian S.
    Guidice, Elena
    Lee, Jung-min
    SEMINARS IN ONCOLOGY, 2024, 51 (1-2) : 45 - 57
  • [32] PARP Inhibitors in Ovarian Cancer
    da Costa, Alexandre
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1572 - 1573
  • [33] PARP Inhibitors for Ovarian Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1535): : 200 - 202
  • [34] PARP INHIBITORS IN OVARIAN CANCER
    Calvert, H.
    Curtin, N.
    Plummer, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 23 - 23
  • [35] PARP inhibitors in ovarian cancer
    Ledermann, J. A.
    ANNALS OF ONCOLOGY, 2016, 27 : 40 - 44
  • [36] PARP inhibitors in ovarian cancer
    Franzese, Elisena
    Centonze, Sara
    Diana, Anna
    Carlino, Francesca
    Guerrera, Luigi Pio
    Di Napoli, Marilena
    De Vita, Ferdinando
    Pignata, Sandro
    Ciardiello, Fortunato
    Orditura, Michele
    CANCER TREATMENT REVIEWS, 2019, 73 : 1 - 9
  • [37] The Effect of the Triazene Compound CT913 on Ovarian Cancer Cells in Vitro and its Interaction with PARP-Inhibitors
    Wichmann, Catharina
    Kuhlmann, Jan Dominik
    Klotz, Daniel Martin
    Zeiler, Hans-Joachim
    Hilger, Ralf Axel
    Wimberger, Pauline
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 216 - 216
  • [38] The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its interaction with PARP-inhibitors
    Wichmann, C.
    Kuhlmann, J. D.
    Klotz, D. M.
    Zeiler, H.
    Hilger, R. A.
    Wimberger, P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (06) : E38 - E38
  • [39] PARP inhibitors in ovarian cancer: evidence for maintenance and treatment strategies
    Bahena-Gonzalez, Antonio
    Toledo-Leyva, Alfredo
    Gallardo-Rincon, Dolores
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
  • [40] Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer
    Tang, Bin
    Wu, Min
    Zhang, Lin
    Jian, Shuyi
    Lv, Shiyi
    Lin, Tongyuan
    Zhu, Shuangshuang
    Liu, Layang
    Wang, Yixue
    Yi, Zhengfang
    Jiang, Feiyun
    FRONTIERS IN ONCOLOGY, 2023, 13
12345